• 1
    American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis. 1993; 148:141826.
  • 2
    American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Am J Respir Care Med. 2001; 163:173054.
  • 3
    Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44(Suppl 2):S2772.
  • 4
    Pham JC, Kelen GD, Pronovost PJ. National study on the quality of emergency department care in the treatment of acute myocardial infarction and pneumonia. Acad Emerg Med. 2007; 14:85663.
  • 5
    Pham JC, Ho GK, Hill PM, McCarthy ML, Pronovost PJ. National study of patient, visit, and hospital characteristics associated with leaving an emergency department without being seen: predicting LWBS. Acad Emerg Med. 2009; 16:94955.
  • 6
    Tang N, Stein J, Hsia RY, Maselli JH, Gonzales R. Trends and characteristics of US emergency department visits, 1997-2007. JAMA. 2010; 304:66470.
  • 7
    Wiler JL, Ross MA, Ginde AA. National study of emergency department observation services. Acad Emerg Med. 2011; 18:95965.
  • 8
    Moran GJ. New directions in antiinfective therapy for community-acquired pneumonia in the emergency department. Pharmacotherapy. 2001; 21(7 pt 2):95S9S.
  • 9
    Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. The cost of treating community-acquired pneumonia. Clin Ther. 1998; 20:82037.
  • 10
    Talan DA, Moran GJ. Emergency department management of pneumonia. Can Respir J. 1999; 6(Suppl A):10A4A.
  • 11
    Barrett TW, Schriger DL. Emergency department crowding is associated with poor care for patients with severe pain. Ann Emerg Med. 2008; 51:67.
  • 12
    Bernstein SL, Aronsky D, Duseja R, et al. The effect of emergency department crowding on clinically oriented outcomes. Acad Emerg Med. 2009; 16:110.
  • 13
    Fee C, Weber EJ, Maak CA, Bacchetti P. Effect of emergency department crowding on time to antibiotics in patients admitted with community-acquired pneumonia. Ann Emerg Med. 2007; 50:5019.
  • 14
    McCaig LF, Burt CW. National Hospital Ambulatory Medical Care Survey: 1999 emergency department summary. Adv Data. 2001; 320:136.
  • 15
    Baine WB, Yu W, Summe JP. Epidemiologic trends in the hospitalization of elderly Medicare patients for pneumonia, 1991-1998. Am J Public Health. 2001; 91:11213.
  • 16
    Henrickson KJ, Kuhn SM, Savatski LL. Epidemiology and cost of infection with human parainfluenza virus types 1 and 2 in young children. Clin Infect Dis. 1994; 18:7709.
  • 17
    Marrie TJ. Pneumococcal pneumonia: epidemiology and clinical features. Semin Respir Infect. 1999; 14:22736.
  • 18
    Jha AK, Shlipak MG, Hosmer W, Frances CD, Browner WS. Racial differences in mortality among men hospitalized in the Veterans Affairs health care system. JAMA. 2001; 285:297303.
  • 19
    McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules. Arch Intern Med. 2009; 169:152531.
  • 20
    Wu JH, Howard DH, McGowan JE Jr, Turpin RS, Henry Hu X. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort. Clin Ther. 2006; 28:145161.
  • 21
    Nathwani D, Rubinstein E, Barlow G, Davey P. Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care? Clin Infect Dis. 2001; 32:72841.
  • 22
    Schwartz DN, Furumoto-Dawson A, Itokazu GS, Chinikamwala M, Levasseur S, Weinstein RA. Preventing mismanagement of community-acquired pneumonia at an urban public hospital: implications for institution-specific practice guidelines. Chest. 1998; 113(3 Suppl):194S8S.
  • 23
    Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997; 278:20804.
  • 24
    Dean NC, Silver MP, Bateman KA. Frequency of subspecialty physician care for elderly patients with community-acquired pneumonia. Chest. 2000; 117:3937.
  • 25
    Marrie TJ, Lau CY, Wheeler SL, Wong CJ, Vandervoort MK, Feagan BG. A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283:74955.
  • 26
    Mortensen EM, Restrepo M, Anzueto A, Pugh J. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia. Am J Med. 2004; 117:72631.
  • 27
    Drake DE, Cohen A, Cohn J. National hospital antibiotic timing measures for pneumonia and antibiotic overuse. Qual Manag Health Care. 2007; 16:11322.
  • 28
    Friedberg MW, Mehrotra A, Linder JA. Reporting hospitals’ antibiotic timing in pneumonia: adverse consequences for patients? Am J Manag Care. 2009; 15:13744.
  • 29
    Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest. 2007; 131:18659.
  • 30
    Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary. Adv Data. 2007; 132.
  • 31
    Wachter RM, Flanders SA, Fee C, Pronovost PJ. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008; 149:2932.
  • 32
    Van Bambeke F, Reinert RR, Appelbaum PC, Tulkens PM, Peetermans WE. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options. Drugs. 2007; 67:235582.
  • 33
    Wallin TR, Hern HG, Frazee BW. Community-associated methicillin-resistant Staphylococcus aureus. Emerg Med Clin North Am. 2008; 26:43155.
  • 34
    Cunha BA. Penicillin resistance in pneumococcal pneumonia. Antibiotics with low resistance potential are effective and pose less risk. Postgrad Med. 2003; 113:424 47–8, 52–4.
  • 35
    Mandell LA. Relationship of penicillin resistance to mortality in pneumococcal pneumonia. Curr Infect Dis Rep. 2001; 3:912.
  • 36
    Coley KC, Skledar SJ, Fine MJ, et al. Changing physician prescribing behavior: the community-acquired pneumonia intervention trial. Am J Health Syst Pharm. 2000; 57:150610.
  • 37
    Whittle J, Fine MJ, Joyce DZ, et al. Community-acquired pneumonia: can it be defined with claims data? Am J Med Qual. 1997; 12:18793.
  • 38
    Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009; 302:75866.
  • 39
    Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008; 299:708.